Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459257) titled 'Psychiatric Symptom Predictors in Methamphetamine-Induced Psychosis' on March 4.
Study Type: Observational
Primary Sponsor: Elazig Mental Health and Diseases Hospital
Condition:
Methamphetamine Induced Psychosis
Recruitment Status: Recruiting
Date of First Enrollment: February 3, 2025
Target Sample Size: 150
Countries of Recruitment:
Turkey (Turkiye)
To know more, visit https://clinicaltrials.gov/study/NCT07459257
Disclaimer: Curated by HT Syndication....